Bank Of America Corp Protalix Bio Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.19 Trillion
- Q3 2024
A detailed history of Bank Of America Corp transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 44,994 shares of PLX stock, worth $82,339. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,994
Previous 111,164
59.52%
Holding current value
$82,339
Previous $130,000
65.38%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PLX
# of Institutions
50Shares Held
3.58MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$1.75 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$796,4390.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$683,9750.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$609,7020.0% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$494,1000.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $91M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...